Provista Diagnostics Email Format
Biotechnology ResearchGeorgia, United States2-10 Employees
Provista Diagnostics is a small biotechnology research company based in Alpharetta, Georgia, operating a CLIA/CAP-certified laboratory to support its diagnostic testing activities. It concentrates on health diagnostics with a focus on women’s health, developing tools to aid clinicians in making timely, informed decisions about patient care. A key element of its pipeline is Videssa, a breast cancer detection test in development that would use blood-based signals to inform screening strategies. In 2022, Provista expanded its offerings with the launch of PCR testing services for urinary tract infections and other conditions in Florida, illustrating a broader testing portfolio beyond COVID-19 screening. The company serves clinicians and healthcare providers seeking reliable diagnostic information to guide treatment and improve health outcomes, anchored by its Alpharetta base in the U.S. biotech ecosystem.